DSM is active worldwide in life science products, performance materials and industrial chemicals. The group develops, produces and markets innovative products and services that are designed to raise the quality of life. DSM's products are used in a wide range of end-use markets and applications, including human and animal nutrition and health, cosmetics, pharmaceuticals, the automotive industry, coatings, the construction industry and the electrics & electronics market. The group has annual sales of around EURO 8 billion and employs about 24,000 people worldwide. DSM is a leading world player in many of the markets in which it operates and has plants and facilities on every continent. The company's head office is in the Netherlands.
DSM's activities are grouped into three clusters: Life Science Products, Performance Materials and Industrial Chemicals. DSM Nutritional Products will remain a separate entity for the time being.
Life Science Products
The Life Science Products cluster's activities are mainly targeted at the pharmaceutical, food and agrochemical industries. These markets offer DSM attractive prospects and good growth opportunities. The main drivers of growth are a growing world population, increasing purchasing power, the aging of the population, growing emphasis on healthy lifestyles, new technological developments and the outsourcing of production activities by pharmaceutical companies.
DSM is an attractive partner for customers in the life science industry. Through the combination of biotechnology (including fermentation and biocatalysis) and organic chemistry, DSM can offer its customers the widest possible range of technologies ("toolbox") and support them with innovations.
The business groups forming part of the Life Science Products cluster achieve major synergistic benefits through intensive collaboration in the field of research and development, in particular in biotechnology and through the shared use of production sites and facilities.
DSM Nutritional Products
DSM Nutritional Products is a global supplier of vitamins, carotenoids (i.e. colorants and antioxidants) and other biochemicals and fine chemicals to the food, feed, health and cosmetics industries.
Annual Report 2004
Net sales Euro 7.7 billion
Net profit Euro 262 million
Net profit per ordinary share Euro 2.51
Dividend per ordinary share Euro 1.75
Capital expenditure (including acquisitions) Euro 334 million
24,180 employees (as at end 2004)
2003: Roche Vitamins and Fine Chemicals Division (Switzerland)
2000: Catalytica Pharmaceuticals (USA)
1998: Gist-brocades (the Netherlands)
1996: Chemie Linz (Austria), Deretil (Spain)